Kathryn Hawk, MD, MHS

Kathryn Hawk, MD, MHS is an attending physician in the Yale New Haven Hospital Emergency Department and an Associate Professor in the Department of Emergency Medicine, the Yale School of Public Health and the Program in Addiction Medicine.  She is a former NIDA K12 sponsored Drug use, Addiction and HIV Research (DAHRS) Scholar, and is board certified in emergency and addiction medicine. She completed her residency training and research fellowship in the Yale University Department of Emergency Medicine.  Her research primarily focuses on the design, testing and implementation of evidence based-care for ED patients with substance use disorders, with a focus on initiating buprenorphine treatment in the ED and maximizing effective linkage to ongoing treatment using innovative strategies.  Her research on reducing opioid-associated mortality through data linkages, overdose prevention and harm reduction strategies, implementation-facilitation ED-initiated buprenorphine, stigma and the dissemination of evidence-based best practices for care of patients with addiction has been funded by the National Institute on Drug Abuse (NIDA) Clinical Trials Network, Centers for Disease Control (CDC), Emergency Medicine Foundation (EMF), Foundation for Opioid Response (FORE), and the Food and Drug Administration (FDA).